|
|
|
|
||
Re: uspto - basic info that will answer your Q "Now
the other USPTO apps pending are lots more relevant to Teva and Kormlyn
litigation -- '456 (dosing w food) and the 2nd patent on combo
dosing ('368) which is 2nd / backup patent that will be useful if Teva
ultimately wins on the IPR of the granted combo dosing patent." you mean '465 (Optimizing Mifepristone Absorption)?final rejection mailed today. think we hear about '368 soon. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
2678 | Re: uspto - basic info that will answer your Q | i760 | 1 | 7/1/2019 2:41:47 PM |
2681 | Re: uspto - basic info that will answer your Q | joeytakasugi | 1 | 7/2/2019 10:58:17 AM |